Home LiteratureArticle Details
PMID: 23209847 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF.

PLoS neglected tropical diseases ·Vol. 6 ·No. 11 ·2012-00-00 ·Pages e1887

Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, Tannenbaum SR

Abstract

Infections caused by dengue virus are a major cause of morbidity and mortality in tropical and subtropical regions of the world. Factors that control transition from mild forms of disease such as dengue fever (DF) to more life-threatening forms such as dengue hemorrhagic fever (DHF) are poorly understood. Consequently, there are no reliable methods currently available for early triage of DHF patients resulting in significant over-hospitalization. We have systematically examined the proteome, cytokines and inflammatory markers in sera from 62 adult dengue patients (44 DF; 18 DHF) with primary DENV infection, at three different times of infection representing the early febrile, defervescence and convalescent stages. Using fluorescent bioplex assays, we measured 27 cytokines in these serum samples. Additionally, we used multiple mass spectrometry methods for iTRAQ-based comparative analysis of serum proteome as well as measurements of protein adducts- 3-nitrotyrosine and 3-chlorotyrosine as surrogate measures of free radical activity. Using multiple methods such as OPLS, MRMR and MSVM-RFE for multivariate feature selection and classification, we report molecular markers that allow prediction of primary DHF with sensitivity and specificity of >80%. This report constitutes a comprehensive analysis of molecular signatures of dengue disease progression and will help unravel mechanisms of dengue disease progression. Our analysis resulted in the identification of markers that may be useful for early prediction of DHF during the febrile phase. The combination of highly sensitive analytical methods and novel statistical approaches described here forms a robust platform for biomarker discovery.

MeSH Terms
Adult Biomarkers/blood Cohort Studies Cytokines/blood Dengue Virus/pathogenicity Female Humans Longitudinal Studies Male Middle Aged Prognosis Proteome/analysis Serum/chemistry Severe Dengue/diagnosis,pathology
Chemicals
Biomarkers Cytokines Proteome
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kumar Yadunanda
Interdisciplinary Research Group in Infectious diseases, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.
Liang Cui
Bo Zheng
Rajapakse Jagath C
Ooi Eng Eong
Tannenbaum Steven R
References (44)
44 references, click to expand
  1. MSVM-RFE: extensions of SVM-RFE for multiclass gene selection on DNA microarray data.
    Bioinformatics. 2007 May 1;23(9):1106-14 PMID: 17494773
  2. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.
    Expert Rev Mol Med. 2009 Jun 30;11:e19 PMID: 19563700
  3. Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever.
    Clin Transl Sci. 2012 Feb;5(1):8-20 PMID: 22376251
  4. Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue.
    Rev Soc Bras Med Trop. 2008 Jan-Feb;41(1):6-10 PMID: 18368263
  5. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity.
    J Med Virol. 1999 Nov;59(3):329-34 PMID: 10502265
  6. Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness.
    PLoS Negl Trop Dis. 2008 Mar 12;2(3):e196 PMID: 18335069
  7. Measurement of protein using bicinchoninic acid.
    Anal Biochem. 1985 Oct;150(1):76-85 PMID: 3843705
  8. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever.
    J Virol. 2007 Feb;81(4):1592-600 PMID: 17151115
  9. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness.
    Vaccine. 2011 May 17;29(22):3895-904 PMID: 21443963
  10. The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever.
    Trans R Soc Trop Med Hyg. 2009 Apr;103(4):413-9 PMID: 19203772
  11. IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba.
    J Med Virol. 2004 Jun;73(2):230-4 PMID: 15122797
  12. Involvement of ROCK-mediated endothelial tension development in neutrophil-stimulated microvascular leakage.
    Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H741-50 PMID: 16172166
  13. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.
    J Virol. 2000 Jun;74(11):4957-66 PMID: 10799569
  14. Early clinical and laboratory indicators of acute dengue illness.
    J Infect Dis. 1997 Aug;176(2):313-21 PMID: 9237695
  15. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand.
    Science. 1960 Apr 15;131(3407):1102-3 PMID: 14399343
  16. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study.
    PLoS One. 2010 Jan 14;5(1):e8709 PMID: 20090849
  17. Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis.
    PLoS One. 2010 Oct 19;5(10):e13277 PMID: 20976045
  18. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
    J Infect Dis. 2000 Jan;181(1):2-9 PMID: 10608744
  19. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue.
    Trans R Soc Trop Med Hyg. 2010 Jan;104(1):16-23 PMID: 19733377
  20. Elevated levels of IL-8 in dengue hemorrhagic fever.
    J Med Virol. 1998 Nov;56(3):280-5 PMID: 9783699
  21. Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients.
    PLoS One. 2010 Dec 29;5(12):e15631 PMID: 21206915
  22. 3-Chlorotyrosine in sputum of COPD patients: relationship with airway inflammation.
    COPD. 2010 Dec;7(6):411-7 PMID: 21166629
  23. A three-component biomarker panel for prediction of dengue hemorrhagic fever.
    Am J Trop Med Hyg. 2012 Feb;86(2):341-8 PMID: 22302872
  24. Inhibition of interferon signaling by dengue virus.
    Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14333-8 PMID: 14612562
  25. Multiple SVM-RFE for gene selection in cancer classification with expression data.
    IEEE Trans Nanobioscience. 2005 Sep;4(3):228-34 PMID: 16220686
  26. Early Dengue infection and outcome study (EDEN) - study design and preliminary findings.
    Ann Acad Med Singap. 2006 Nov;35(11):783-9 PMID: 17160194
  27. Cost-effective real-time reverse transcriptase PCR (RT-PCR) to screen for Dengue virus followed by rapid single-tube multiplex RT-PCR for serotyping of the virus.
    J Clin Microbiol. 2007 Mar;45(3):935-41 PMID: 17215345
  28. The burden of dengue infection.
    Lancet. 2007 Apr 28;369(9571):1410-1411 PMID: 17467495
  29. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents.
    Mol Cell Proteomics. 2004 Dec;3(12):1154-69 PMID: 15385600
  30. The impact of dengue on liver function as evaluated by aminotransferase levels.
    Braz J Infect Dis. 2007 Aug;11(4):407-10 PMID: 17873994
  31. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study.
    Am J Trop Med Hyg. 2009 May;80(5):846-55 PMID: 19407136
  32. Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators.
    PLoS Negl Trop Dis. 2010 Aug 03;4(8):e769 PMID: 20689812
  33. Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production.
    BMC Infect Dis. 2010 Dec 17;10:356 PMID: 21167041
  34. Markers of dengue disease severity.
    Curr Top Microbiol Immunol. 2010;338:67-82 PMID: 19802579
  35. Minimum redundancy feature selection from microarray gene expression data.
    J Bioinform Comput Biol. 2005 Apr;3(2):185-205 PMID: 15852500
  36. Classification of dengue illness based on readily available laboratory data.
    Am J Trop Med Hyg. 2010 Oct;83(4):781-8 PMID: 20889865
  37. Orthogonal projections to latent structures as a strategy for microarray data normalization.
    BMC Bioinformatics. 2007 Jun 18;8:207 PMID: 17577396
  38. Human skin Langerhans cells are targets of dengue virus infection.
    Nat Med. 2000 Jul;6(7):816-20 PMID: 10888933
  39. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
    Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9 PMID: 2665015
  40. Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients.
    J Proteome Res. 2009 Dec;8(12):5431-41 PMID: 19845402
  41. Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection.
    BMC Infect Dis. 2005 Aug 18;5:64 PMID: 16109165
  42. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.
    Trop Med Int Health. 2008 Nov;13(11):1328-40 PMID: 18803612
  43. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.
    BMC Infect Dis. 2008 Jun 25;8:86 PMID: 18578883
  44. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels.
    Am J Trop Med Hyg. 2005 Jun;72(6):786-91 PMID: 15964964
Article Info
Journal
PLoS neglected tropical diseases
Abbr.
PLoS Negl Trop Dis
ISSN
1935-2735
Published
2012-00-00
Epub
2012-00-29
Pages
e1887
Language
English
Region
United States
NLM ID
101291488
PMCID
PMC3510095
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com